1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsFund for a Resilient Nevada (FRN) is sponsored by Nevada Department of Health and Human Services (DHHS) Director’s Office. Supports innovative applications focused on opioid abatement in Nevada, supplementing existing funding to establish new projects and programs.
Get alerted about grants like this
Get emailed when new opportunities from “Nevada Department of Health and Human Services (DHHS) Director’s Office” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Fund for a Resilient Nevada Fund for a Resilient Nevada The use, misuse, and abuse of opioids is one of the deadliest drug epidemics in American history. Opioid addiction touches every corner of the United States and has affected Nevada more severely than other states.
Legal actions, spearheaded by the Nevada Attorney General, concerning the manufacture, distribution, sale or marketing of opioids are helping Nevada and other states deal with the devastating effects of this epidemic on individuals, their families and communities. For more detail, see the Attorney General's "Opioid Epidemic" web page .
Nevada's share of monies recovered from these actions are deposited into the Fund for a Resilient Nevada (FRN) to then be used to mitigate the harms, risks, and impacts of the opioid epidemic. A portion of the funding is administered by DHS, which is responsible the development of the Nevada Opioids Needs Assessment and Statewide Plan.
pdf (last updated 2022) to identify priorities related to addressing opioid-related risk, harms and impacts using a data-driven and evidence-based approach. This assessment is updated every four year. To read the law related to FRN, see Nevada Revised Statutes Ch.
433. 732. Each year by Jan.
31, DHS submits a report concerning all findings, recommendations and money expended from FRN. This report goes to the Governor, Director of the Legislative Counsel Bureau, the Commission on Behavioral Health, Nevada's regional behavioral health policy boards, the Office of the Attorney General, and any other committees or commissions as designated by the DHS director. Fund for a Resilient Nevada NRS 4333.
734 Annual Report (2026) Fund for a Resilient Nevada NRS 433. 734 Annual Report (2025) Fund for a Resilient Nevada NRS 433. 734 Annual Report (2024) Fund for a Resilient Nevada NRS 433.
734 Annual Report (2023) Opioids Recoveries Approved Uses Use of Funds - Allergan Settlement Use of Funds - American Drug Stores Settlement Use of Funds - CVS Settlement Use of Funds - Distributors Settlement Use of Funds - Janssen J&J Settlement Use of Funds - NOAT II Mallinkrodt Bankruptcy Use of Funds - Teva Settlement Use of Funds - Walgreens Settlement Use of Funds - Walmart Settlement Fund for a Resilient Nevada Listserv
According to the current listing, eligibility includes: Nonprofits, public agencies, and for-profit businesses in Nevada. Confirm the full requirements in the official notice before applying.
Fund for a Resilient Nevada (FRN) is funded by Nevada Department of Health and Human Services (DHHS) Director’s Office. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Nevada. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
The STOMP program funds measurement tools and removal therapies for microplastics in human tissue. Proposals due June 22. Eligibility, phases, and strategy.
Read articleRWJF's Health Equity Research for Action puts up ~20 grants of up to $500,000 — but demands a two-year community partnership and a community co-PI. Here's the strategy, set against the brightest foundation-giving outlook since 2022.
Read articleCMS awarded all 50 states a slice of the $50 billion Rural Health Transformation Program on December 29, 2025 — first-year checks average $200M, ranging from $147M to $281M. The federal application is closed and you cannot apply to CMS. The money reaches hospitals, clinics, and nonprofits only as state subawards, and those competitions open through 2026. Here is how the formula worked, what the funds can and cannot buy, and how to position for a subaward before the money starts flowing.
Read article